Impurity reference standards
Ritlecitinib impurities & reference standards
Characterised Ritlecitinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
13reference materials
COAHPLC · NMR · MS on request
Parent API: Ritlecitinib
1792180-81-4 · C15H19N5O
![1-((2R,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one chemical structure](/media/structures/CBRJPFGIXUFMTM-GHMZBOCLSA-N.svg)
1-((2R,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
- CAS
- 1792181-98-6
- Formula
- C15H19N5O
- MW
- 285.34 g/mol
VQ-033578
![1-((2S,5S)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one chemical structure](/media/structures/CBRJPFGIXUFMTM-QWRGUYRKSA-N.svg)
1-((2S,5S)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
- CAS
- 1792181-97-5
- Formula
- C15H19N5O
- MW
- 285.34 g/mol
VQ-033577
![4-Ethoxy-7H-pyrrolo[2,3-d]pyrimidine chemical structure](/media/structures/KPSBLSBABRIUJP-UHFFFAOYSA-N.svg)
Benzyl (2S,5S)-5-amino-2-methylpiperidine-1-carboxylate
- CAS
- 1290191-79-5
- Formula
- C14H20N2O2
- MW
- 248.32 g/mol
VQ-032908
Phenylmethyl (2R,5R)-5-amino-2-methyl-1-piperidinecarboxylate
- CAS
- 1207853-72-2
- Formula
- C14H20N2O2
- MW
- 248.32 g/mol
VQ-032907
Phenylmethyl (2R,5S)-5-amino-2-methyl-1-piperidinecarboxylate
- CAS
- 1290191-65-9
- Formula
- C14H20N2O2
- MW
- 248.32 g/mol
VQ-032906
FAQs — Ritlecitinib impurities
Which Ritlecitinib impurities do you supply?
We list 13 Ritlecitinib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Ritlecitinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Ritlecitinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Ritlecitinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.